Advertisement
Research ArticleArticle

The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib

Yoshihiro Shibata and Masato Chiba
Drug Metabolism and Disposition March 2015, 43 (3) 375-384; DOI: https://doi.org/10.1124/dmd.114.061424
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Pharmacokinetics of Targeted Covalent Inhibitors

Yoshihiro Shibata and Masato Chiba
Drug Metabolism and Disposition March 1, 2015, 43 (3) 375-384; DOI: https://doi.org/10.1124/dmd.114.061424
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement